Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer — Stella
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(86 sites)
United States
Mount Sinai Medical Center, Miami Beach, Florida
USF College of Medicine, Tampa, Florida
Dana-Farber Cancer Institute, Boston, Massachusetts
Beth Israel Lahey Health, Burlington, Massachusetts
Overlook Medical Center, Summit, New Jersey
Australia
Mater Hospital Sydney, North Sydney, New South Wales
Monash Medical Centre Moorabbin, East Bentleigh, Victoria
GenesisCare St Andrews Hospital, Adelaide
Fiona Stanley Hospital, Murdoch
Belgium
Institut Jules Bordet, Anderlecht
GZA Ziekenhuizen, Antwerp
Universitair Ziekenhuis Brussel, Brussels
Cliniques Universitaires Saint-Luc, Brussels
UZ Leuven, Leuven
Centre Hospitalier Universitaire de Liege Sart-Tilman, Liège
GZA Ziekenhuizen, Wilrijk
Brazil
Centro de Oncologia - Unidade Brasília - Hospital Sírio Libanês, Brasília
CIONC-Centro Integrado de Oncologia de Curitiba, Curitiba
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer, Curitiba
CEPON - Centro de Pesquisas Oncológicas de Santa Catarina, Florianópolis
Oncosite - Centro de Pesquisa Clinica e Oncologia, Ijuí
Fundação Doutor Amaral Carvalho, Jaú
Instituto de Cancer de Londrina, Londrina
Hospital das Clínicas FMRP-USP, Riberão Preto
Hospital Nossa Senhora da Conceicao, Rio Grande
Ensino e Terapia de Inovação Clínica AMO-ETICA, Salvador
Catarina Pesquisa Clinica, Santa Catarina
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, São José do Rio Preto
China
Beijing Hospital, Beijing
307 Hospital of PLA, Beijing
Fujian Cancer Hospital, Fujian
Sun Yat sen University Cancer Center, Guangzhou
Zhejiang Cancer Hospital, Hangzhou
Anhui Provincial Cancer Hospital, Hefei
Shandong Cancer Hospital, Jinan
Yunnan Cancer Hospital, Kunming
Nanchang People's Hospital, Nanchang
Jiangxi Cancer Hospital, Nanchang
The Affiliated Hospital of Qingdao University, Qingdao
Fudan University Shanghai Cancer Center, Shanghai
Henan Cancer Hospital, Zhengzhou
Ireland
Cork University Hospital, Cork
St Vincent's University Hospital, Dublin
St James Hospital, Dublin
Beaumont Hospital, Dublin
Galway University Hospital, Galway
Italy
Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari
Azienda Ospedaliera Universitaria Policlinico Sant Orsola Malpighi IRCCS, Bologna
Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova
Ospedale San Raffaele, Milan
Humanitas Istituto Clinico Catanese, Misterbianco
Istituto Nazionale Tumori Fondazione G Pascale, Naples
IOV - Istituto Oncologico Veneto IRCCS, Padova
Nuovo Ospedale di Prato, Prato
Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Rome